ClinicalTrials.Veeva

Menu

Managing Insulin With a Voice AI (MIVA)

Stanford University logo

Stanford University

Status

Completed

Conditions

Medication Adherence

Treatments

Device: Voice Assistant Device

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.

Enrollment

39 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with Type 2 Diabetes
  • Patients clinically indicated to be taking daily long-acting insulin
  • Patients currently taking long-acting insulin but necessitating active dose adjustments

Exclusion criteria

  • Patients who do not speak English
  • Patients who do not own a smart phone
  • Patients who do not have stable wireless internet connection at home

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

39 participants in 2 patient groups

Voice Assistant Device
Experimental group
Description:
Subjects have their insulin titrated by a voice assistant device for 8 weeks. The Voice Assistant Device software algorithm is used to provide daily insulin dose and titration instructions.
Treatment:
Device: Voice Assistant Device
Device: Voice Assistant Device
Control
Active Comparator group
Description:
Subjects have their insulin titrated via standard of care for 8 weeks. The Voice Assistant Device is limited to providing a daily reminder to take medication.
Treatment:
Device: Voice Assistant Device
Device: Voice Assistant Device

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems